This was the stock's second consecutive day of gains.

Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best biotech stocks to invest in now. On June 20, Vertex ...

One-year results from the company's FORWARD-101 trial of islet cell therapy zimislecel (also known as VX-880) showed that all ...

A study may have found a cure for type 1 diabetes. Here, experts explain how the treatment, zimislecel, works and what it ...

A single infusion of a new stem cell-based treatment may have helped 10 out of 12 people with severe type 1 diabetes stop using insulin, researchers report. The treatment, called zimislecel, was made ...

Ten people have been effectively cured of their type 1 diabetes after a breakthrough infusion of a new treatment on the path ...

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...

A small study found that a stem cell-derived treatment helped people with Type 1 diabetes produce their own insulin and, in most cases, enabled patients to discontinue use of external insulin ...

In phase 2 of the FORWARD study, 83% of participants with type 1 diabetes achieved insulin independence a year after receiving zimislecel (formerly VX-880), an islet cell therapy developed ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.